SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-003806
Filing Date
2022-03-17
Accepted
2022-03-17 08:11:29
Documents
118
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20211231x20f.htm   iXBRL 20-F 3560716
2 EX-4.9 rdhl-20211231xex4d9.htm EX-4.9 135961
3 EX-4.10 rdhl-20211231xex4d10.htm EX-4.10 186754
4 EX-4.11 rdhl-20211231xex4d11.htm EX-4.11 112080
5 EX-4.14 rdhl-20211231xex4d14.htm EX-4.14 16478
6 EX-4.19 rdhl-20211231xex4d19.htm EX-4.19 75751
7 EX-12.1 rdhl-20211231xex12d1.htm EX-12.1 12353
8 EX-12.2 rdhl-20211231xex12d2.htm EX-12.2 12986
9 EX-13 rdhl-20211231xex13.htm EX-13 8594
10 EX-15.1 rdhl-20211231xex15d1.htm EX-15.1 6520
11 GRAPHIC rdhl-20211231x20f010.jpg GRAPHIC 1625
12 GRAPHIC rdhl-20211231xex4d10001.jpg GRAPHIC 3615
13 GRAPHIC rdhl-20211231xex4d11001.jpg GRAPHIC 3009
14 GRAPHIC rdhl-20211231xex15d1001.jpg GRAPHIC 2286
  Complete submission text file 0001558370-22-003806.txt   12592604

Data Files

Seq Description Document Type Size
15 EX-101.SCH rdhl-20211231.xsd EX-101.SCH 93710
16 EX-101.CAL rdhl-20211231_cal.xml EX-101.CAL 59821
17 EX-101.DEF rdhl-20211231_def.xml EX-101.DEF 302628
18 EX-101.LAB rdhl-20211231_lab.xml EX-101.LAB 630268
19 EX-101.PRE rdhl-20211231_pre.xml EX-101.PRE 502591
112 EXTRACTED XBRL INSTANCE DOCUMENT rdhl-20211231x20f_htm.xml XML 2179173
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 22746835
SIC: 2834 Pharmaceutical Preparations